↓ Skip to main content

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders

Overview of attention for article published in Journal of Hematology & Oncology, May 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
9 X users

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
Published in
Journal of Hematology & Oncology, May 2022
DOI 10.1186/s13045-022-01275-7
Pubmed ID
Authors

José Luis Piñana, Lucia López-Corral, Rodrigo Martino, Lourdes Vazquez, Ariadna Pérez, Gabriel Martin-Martin, Beatriz Gago, Gabriela Sanz-Linares, Andrés Sanchez-Salinas, Lucia Villalon, Venancio Conesa-Garcia, María T. Olave, Magdalena Corona, Sara Marcos-Corrales, Mar Tormo, José Ángel Hernández-Rivas, Juan Montoro, Alicia Rodriguez-Fernandez, Irene Risco-Gálvez, Pablo Rodríguez-Belenguer, Juan Carlos Hernandez-Boluda, Irene García-Cadenas, Montserrat Ruiz-García, Juan Luis Muñoz-Bellido, Carlos Solano, Ángel Cedillo, Anna Sureda, David Navarro

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 11%
Researcher 5 11%
Student > Ph. D. Student 5 11%
Student > Bachelor 4 9%
Student > Doctoral Student 1 2%
Other 5 11%
Unknown 22 47%
Readers by discipline Count As %
Medicine and Dentistry 11 23%
Nursing and Health Professions 3 6%
Immunology and Microbiology 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Economics, Econometrics and Finance 1 2%
Other 3 6%
Unknown 26 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2022.
All research outputs
#5,430,664
of 25,732,188 outputs
Outputs from Journal of Hematology & Oncology
#460
of 1,300 outputs
Outputs of similar age
#114,347
of 447,201 outputs
Outputs of similar age from Journal of Hematology & Oncology
#22
of 43 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,300 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,201 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.